Beta Bionics, Inc. (BBNX) Gains from Investment Securities (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Gains from Investment Securities data on file, last reported at $1000.0 in Q1 2026.

• Quarterly Gains from Investment Securities fell 99.99% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.8 million (down 256.26% YoY) and the FY2025 annual result came in at $6.5 million, up 13.86% from the prior year.
• Gains from Investment Securities rose to $1000.0 in Q1 2026 per BBNX's latest filing, from -$12.4 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $8.2 million in Q1 2025, with the low at -$12.4 million in Q4 2025.
• Average Gains from Investment Securities over 4 years is $863559.1, with a median of $123067.0 recorded in 2025.
• The widest YoY moves for Gains from Investment Securities: up 137.31% in 2025, down 1241900.0% in 2025.
• Beta Bionics' Gains from Investment Securities stood at $5.2 million in 2023, then slumped by 100.02% to -$1000.0 in 2024, then tumbled by 1241900.0% to -$12.4 million in 2025, then surged by 100.01% to $1000.0 in 2026.
• Business Quant data shows BBNX's Gains from Investment Securities at $1000.0 in Q1 2026, -$12.4 million in Q4 2025, and $156340.0 in Q3 2025.